阿尼科利德D通过PI3K/Akt/mTOR通路抑制骨髓瘤细胞的增殖并诱导骨髓瘤细胞的亡
Zhuo Chen1, Renhua Ni1, Yuanyu Hu1
1Department of Orthopedics, Peking University Third Hospital, Beijing, 100191, China.
Anti-cancer agents in medicinal chemistry
|July 5, 2024
概括
传统中医药中的一种化合物Arnicolide D有效地抑制骨髓瘤细胞的生长和扩散. 这种天然化合物显示出作为未来骨癌治疗候选者的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 骨髓瘤是一种主要的骨癌,需要新的治疗方法.
- 来自*Centipeda minima*的Arnicolide D已经在其他癌症中显示出抗癌作用.
- 目前尚不清楚Arnicolide D对骨髓瘤的疗效.
研究的目的:
- 为了评估Arnicolide D在骨髓瘤细胞中的抗癌活性.
- 为了阐明Arnicolide D作用背后的分子机制.
- 为了研究对MG63和U2OS骨髓瘤细胞系的影响.
主要方法:
- MTT和殖民地形成试验评估了细胞活力和增殖.
- 流细胞计分析了细胞周期进展和细胞亡.
- 西部涂抹检测到PI3K/Akt/mTOR通路的激活.
主要成果:
- 阿尼科利德D显著降低了细胞活力和增殖.
- 治疗诱导的亡和G2/M细胞周期停止.
- 阿尼科利德D抑制了PI3K/Akt/mTOR信号通路.
结论:
- 阿尼科利德D具有显著的抗骨髓瘤活性.
- 该化合物显示出作为治疗骨髓瘤的治疗剂的潜力.
- 进一步的研究可能会确定Arnicolide D作为一种可行的治疗选择.
更多相关视频
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.1K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
